Nature Communications · 2017 · 176 citations · 21 references
MedicineImmunologyOncologyCancer ImmunologyMetastasisTumor ImmunologyAngiogenesisAngiogenesis In CancerCellular Responses To HypoxiaHypoxia AdaptationNatural Killer Cell BiologyNatural Killer Cell FunctionAngiogenesis In NeoplasmsHif-1 SignalingHypoxia-dependent GrowthHypoxia-inducible Factor SignalingHypoxia-inducible SignalingLow-oxygen AdaptationLow-oxygen StressTumor Microenvironment Hypoxia
Productive angiogenesis, a prerequisite for tumour growth, depends on the balanced release of angiogenic and angiostatic factors by different cell types within hypoxic tumours. Natural killer (NK) cells kill cancer cells and infiltrate hypoxic tumour areas. Cellular adaptation to low oxygen is mediated by Hypoxia-inducible factors (HIFs). We found that deletion of HIF-1α in NK cells inhibited tumour growth despite impaired tumour cell killing. Tumours developing in these conditions were characterised by a high-density network of immature vessels, severe haemorrhage, increased hypoxia, and facilitated metastasis due to non-productive angiogenesis. Loss of HIF-1α in NK cells increased the bioavailability of the major angiogenic cytokine vascular endothelial growth factor (VEGF) by decreasing the infiltration of NK cells that express angiostatic soluble VEGFR-1. In summary, this identifies the hypoxic response in NK cells as an inhibitor of VEGF-driven angiogenesis, yet, this promotes tumour growth by allowing the formation of functionally improved vessels.
21
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
David W. M. Leung, George Cachianes, Wun-Jing Kuang et al. · Science · 1989 · 5K citations
Transplacental Carcinogenesis by Stilbestrol
Judah Folkman · New England Journal of Medicine · 1971 · 2.6K citations
Pharmacy, Oncology, Toxicology +17
Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis
Irene Noguera‐Troise, Christopher Daly, Nicholas Papadopoulos et al. · Nature · 2006 · 1K citations
Medicine, Cancer Biology, Oncology +14